Alunbrig (brigatinib)

pCPA File Number: 21467
Negotiation Status:
Under consideration for negotiation
Indication(s):
Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
Takeda Canada Inc.
CADTH Project Number:
PC0230-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable